(S (NP-SBJ (NP (NN Cell) (NN cycle) (NN analysis)) (PP (IN of) (NP (NP (NN E2F)) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS cells)))))) (VP (VBZ reveals) (NP-COOD (NP (JJ novel) (NN E2F) (NNS complexes)) (CC and) (NP (NP (ADJP (RB biochemically) (JJ distinct)) (NNS forms)) (PP (IN of) (NP (JJ free) (NN E2F)))))) (. .))
(S (NP-SBJ (DT The) (NN transcription) (NN factor) (NN E2F)) (VP (VBZ activates) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ multiple) (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN cell) (NN proliferation)))) (, ,) (PP (JJ such) (IN as) (NP-COOD (NP (NN c-myc)) (CC and) (NP (DT the) (JJ dihydrofolate) (NN reductase) (NN gene)))))))) (. .))
(S (NP-SBJ (NP (NN Regulation)) (PP (IN of) (NP (NN E2F)))) (VP (VBZ involves) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (JJ cellular) (NNS proteins)) (, ,) (PP (VBG including) (NP-COOD (NP (NP (DT the) (NN retinoblastoma) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN Rb)) (-RRB- -RRB-))) (, ,) (NP (DT the) (JJ Rb-related) (NN protein) (NN p107)) (, ,) (NP (NN cyclin) (NN A)) (, ,) (CC and) (NP (NN cdk2)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD undertook) (NP (NP (DT a) (JJ detailed) (NN analysis)) (PP (IN of) (NP (NP-COOD (NP (NN E2F) (JJ DNA-binding) (NNS activities)) (CC and) (NP (PRP$ their) (NN cell) (NN cycle) (NN behavior))) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS cells))))))) (. .))
(S (NP-SBJ-9 (CD Three) (NN E2F) (JJ DNA-binding) (NNS activities)) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (VBG resting) (-LRB- -LRB-) (NN G0) (-RRB- -RRB-) (NN T) (NNS cells))) (S (NP-SBJ (-NONE- *-9)) (PP-PRD (IN with) (NP (NP (NNS mobilities)) (ADJP (PP (IN in) (NP (NN gel) (NN shift) (NNS assays))) (JJ distinct) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (ADJP (RB previously) (VBN defined)) (NN E2F) (NNS complexes))))))))))) (. .))
(S (NP-SBJ-11 (NP (CD One)) (PP (IN of) (NP (DT these) (NNS activities)))) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-11)) (VP (TO to) (VP (VB be) (NP-PRD (DT a) (ADJP-COOD (ADJP (JJ novel)) (, ,) (ADJP (RBR less) (JJ abundant)) (, ,) (ADJP (NN Rb-E2F))) (NN complex))))))) (. .))
(S (NP-SBJ (NP (DT The) (ADJP (RBS most) (JJ prominent)) (NN E2F) (NN activity)) (PP (IN in) (NP (VBG resting) (NN T) (NNS cells))) (-LRB- -LRB-) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (JJ complex) (NN X)))) (-RRB- -RRB-)) (VP (VP-COOD (VP (VBD was) (ADJP-PRD (JJ abundant)) (PP (IN in) (NP-COOD (CC both) (NP (NN G0)) (CC and) (NP (NN G1))))) (CC but) (VP (VBD disappeared) (SBAR-TMP (IN as) (S (NP-SBJ (NNS cells)) (VP (VBD entered) (NP (NN S) (NN phase))))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN in) (NP (ADJP (RB negatively) (VBG regulating)) (NN E2F) (NN function))))))) (. .))
(S (NP-SBJ-12 (NN Complex) (NN X)) (VP (MD could) (VP (VB be) (VP (VBN dissociated) (NP (-NONE- *-12)) (PP (IN by) (NP-LGS (NN adenovirus) (NN E1A))) (PP (IN with) (NP (NP (DT a) (NN requirement)) (PP (IN for) (NP (DT an) (JJ intact) (NN E1A) (VBN conserved) (NN region) (CD 2)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-13 (NN X)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-13)) (VP (TO to) (VP (VB react) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS antibodies)) (PP (IN against) (NP-COOD (NP (NN Rb)) (CC or) (NP (NN p107))))))))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG implicating) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (DT an) (JJ E1A-binding) (NN protein)) (PP (JJ other) (IN than) (NP-COOD (NP (NN Rb)) (CC or) (NP (NN p107)))))))))) (. .))
(S (PP (IN In) (NN addition) (TO to) (NP (DT these) (JJ novel) (NN E2F) (NNS complexes))) (, ,) (NP-SBJ-14 (NP (CD three) (JJ distinct) (NNS forms)) (PP (IN of) (NP (ADJP (ADJP (JJ unbound)) (PRN (-LRB- -LRB-) (ADJP (JJ free)) (-RRB- -RRB-))) (NN E2F)))) (VP (VBD were) (VP (VBN resolved) (NP (-NONE- *-14)) (PP (IN in) (NP (NN gel) (NN shift) (NNS experiments))))) (. .))
(S (NP-SBJ (DT These) (NNS species)) (VP (VBD showed) (NP (JJ different) (NN cell) (NN cycle) (NNS kinetics))) (. .))
(S (NP-SBJ (NN UV) (JJ cross-linking) (NNS experiments)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-15 (DT a) (JJ distinct) (NN E2F) (JJ DNA-binding) (NN protein)) (VP-COOD (VP (VBZ is) (VP (ADVP (RB uniquely)) (VBN associated) (NP (-NONE- *-15)) (PP (IN with) (NP (DT the) (NN S-phase) (NN p107) (NN complex))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN associated) (NP (-NONE- *-15)) (PP (IN with) (NP (NN Rb))))))))) (. .))
(S (ADVP (RB Together)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN E2F)) (VP (VBZ consists) (PP (IN of) (NP (NP (ADJP-COOD (ADJP (JJ multiple)) (, ,) (ADJP (RB biochemically) (JJ distinct))) (JJ DNA-binding) (NNS proteins)) (SBAR (WHNP-16 (WDT which)) (S (NP-SBJ (-NONE- *T*-16)) (VP (VBP function) (PP-TMP (IN at) (NP (NP (JJ different) (NNS points)) (PP (IN in) (NP (DT the) (NN cell) (NN cycle)))))))))))))) (. .))
